Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.22 - $8.26 $8,352 - $13,216
1,600 Added 3.19%
51,700 $421,000
Q2 2024

Aug 14, 2024

BUY
$6.1 - $10.41 $305,610 - $521,541
50,100 New
50,100 $349,000
Q4 2023

Feb 14, 2024

SELL
$6.53 - $8.23 $860,654 - $1.08 Million
-131,800 Reduced 77.39%
38,500 $308,000
Q3 2023

Nov 15, 2023

BUY
$7.69 - $9.71 $1.31 Million - $1.65 Million
170,300 New
170,300 $1.4 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.77B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.